Product Code: ETC6189723 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Beyond RIDTs, this broader market includes molecular and antigen-based diagnostics for influenza viruses. The market is evolving with improvements in sensitivity and specificity, helping healthcare providers differentiate between influenza strains quickly. Investment in research and improved access to diagnostic tools in rural and remote areas are important market drivers.
The broader influenza diagnostics market is shifting towards digital and connected rapid testing solutions. Innovation in biosensors and mobile diagnostics is helping integrate influenza testing into telemedicine platforms. Government vaccination and preparedness campaigns also boost test utilization during flu seasons.
This broader market faces limitations due to fluctuating demand outside flu seasons, evolving influenza virus strains that reduce test effectiveness, and competition from high-throughput laboratory-based PCR diagnostics. Public skepticism around test reliability also affects adoption rates.
Beyond RIDTs, the broader influenza diagnostics market includes molecular and antigen-based platforms. With growing demand for at-home and rapid clinical testing, investors can explore joint ventures in device innovation, mobile health applications, and distribution networks. Technological advancements in multiplex testing also offer differentiated opportunities.
This broader category, encompassing various influenza diagnostics beyond RIDTs, benefits from similar government strategies. Public hospitals and pathology labs receive government funding to deploy rapid influenza diagnostics during peak seasons. Surveillance programs also employ these tests to track and contain outbreaks, with government-led procurement driving demand and ensuring stockpiles are maintained.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Rapid Influenza Diagnostics Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Rapid Influenza Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Rapid Influenza Diagnostics Market - Industry Life Cycle |
3.4 Australia Rapid Influenza Diagnostics Market - Porter's Five Forces |
3.5 Australia Rapid Influenza Diagnostics Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.6 Australia Rapid Influenza Diagnostics Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.7 Australia Rapid Influenza Diagnostics Market Revenues & Volume Share, By End user, 2021 & 2031F |
3.8 Australia Rapid Influenza Diagnostics Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Australia Rapid Influenza Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of influenza cases in Australia |
4.2.2 Growing awareness about the importance of early and accurate diagnosis of influenza |
4.2.3 Technological advancements in rapid influenza diagnostic tests |
4.3 Market Restraints |
4.3.1 High cost associated with rapid influenza diagnostic tests |
4.3.2 Limited access to healthcare facilities in certain regions of Australia |
4.3.3 Regulatory challenges and approvals for new diagnostic products |
5 Australia Rapid Influenza Diagnostics Market Trends |
6 Australia Rapid Influenza Diagnostics Market, By Types |
6.1 Australia Rapid Influenza Diagnostics Market, By Disease |
6.1.1 Overview and Analysis |
6.1.2 Australia Rapid Influenza Diagnostics Market Revenues & Volume, By Disease, 2021- 2031F |
6.1.3 Australia Rapid Influenza Diagnostics Market Revenues & Volume, By Influenza A, 2021- 2031F |
6.1.4 Australia Rapid Influenza Diagnostics Market Revenues & Volume, By Influenza B, 2021- 2031F |
6.2 Australia Rapid Influenza Diagnostics Market, By Test Type |
6.2.1 Overview and Analysis |
6.2.2 Australia Rapid Influenza Diagnostics Market Revenues & Volume, By STANDARD F Influenza A/B Fluorescence Immunoassay (STANDARD F), 2021- 2031F |
6.2.3 Australia Rapid Influenza Diagnostics Market Revenues & Volume, By Sofia Influenza A?+?B Fluorescence Immunoassay (Sofia), 2021- 2031F |
6.2.4 Australia Rapid Influenza Diagnostics Market Revenues & Volume, By Immunochromatographic Assay, 2021- 2031F |
6.2.5 Australia Rapid Influenza Diagnostics Market Revenues & Volume, By Real-Time Polymerase Chain Reaction (RT-PCR), 2021- 2031F |
6.2.6 Australia Rapid Influenza Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Australia Rapid Influenza Diagnostics Market, By End user |
6.3.1 Overview and Analysis |
6.3.2 Australia Rapid Influenza Diagnostics Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
6.3.3 Australia Rapid Influenza Diagnostics Market Revenues & Volume, By Laboratories, 2021- 2031F |
6.3.4 Australia Rapid Influenza Diagnostics Market Revenues & Volume, By Other, 2021- 2031F |
6.4 Australia Rapid Influenza Diagnostics Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Australia Rapid Influenza Diagnostics Market Revenues & Volume, By Direct, 2021- 2031F |
6.4.3 Australia Rapid Influenza Diagnostics Market Revenues & Volume, By Retail, 2021- 2031F |
7 Australia Rapid Influenza Diagnostics Market Import-Export Trade Statistics |
7.1 Australia Rapid Influenza Diagnostics Market Export to Major Countries |
7.2 Australia Rapid Influenza Diagnostics Market Imports from Major Countries |
8 Australia Rapid Influenza Diagnostics Market Key Performance Indicators |
8.1 Adoption rate of rapid influenza diagnostic tests by healthcare facilities |
8.2 Number of partnerships and collaborations between diagnostic test manufacturers and healthcare providers |
8.3 Rate of development and launch of innovative rapid influenza diagnostic products |
8.4 Level of government funding and support for influenza diagnostic initiatives |
8.5 Number of influenza outbreaks and cases diagnosed using rapid tests in Australia |
9 Australia Rapid Influenza Diagnostics Market - Opportunity Assessment |
9.1 Australia Rapid Influenza Diagnostics Market Opportunity Assessment, By Disease, 2021 & 2031F |
9.2 Australia Rapid Influenza Diagnostics Market Opportunity Assessment, By Test Type, 2021 & 2031F |
9.3 Australia Rapid Influenza Diagnostics Market Opportunity Assessment, By End user, 2021 & 2031F |
9.4 Australia Rapid Influenza Diagnostics Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Australia Rapid Influenza Diagnostics Market - Competitive Landscape |
10.1 Australia Rapid Influenza Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 Australia Rapid Influenza Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |